API
Click for more information
0.00% $1.53 australian pharmaceutical industries limited

Ann: API Board rejects indicative proposal from Wesfarmers, page-18

  1. apoel
    1,271 Posts.
    lightbulb Created with Sketch. 62
    clock Created with Sketch.
    13/09/21
    10:58
    Post #: 56014791
    The way that WES is behaving doesn't make sense.
    I assume they have identified Pharmacy as a strategic segment to be in.
    Once they have done that, to try to penny-pinch makes no sense, especially when API is so small compared to them (1% of their market cap)
    API Price at posting: $1.33 Sentiment: None Disclosure: Not Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

SBW Shekel Brainweigh provides key business update ahead of final 2024 quarter
right-arrow Created with Sketch.
RDN Raiden Resources hopeful it can start drilling Andover South, WA, as early as mid-October
right-arrow Created with Sketch.
NEWS How institutional adoption is shaping the future of crypto
right-arrow Created with Sketch.
watchlist Created with Sketch. Add API (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.